The results of the INNOVCare Project (Innovative Patient-Centred Approach for Social Care Provision to Complex Conditions) were announced at the final project conference in Brussels on 5 September, to 80 participants from 18 countries across all stakeholders. The results demonstrate the...

From 13-14 September, the ePAG Steering Committee met in Brussels, with Dalia Aminoff and Serena Bartezzati representing eUROGEN. Birute Tumiene, a geneticist from Vilnius University Hospital Santaros Klinikos, and Representative of Lithuania in the ERN Board of Member States...

New call for proposals A new call for ERNs to apply to the Connecting European Facilities Fund (CEF) was published on 28 June 2018, with a submission deadline of 22 September 2018.  The grant will fund activities related to...

Genetic Alliance UK (the national charity alliance of over 200 patient organisations working to improve the lives of patients and families affected by all types of genetic conditions) held an event at the Houses of Parliament, London, on 9...

Prof Wout Feitz (WS1 Lead) (NL) and Michelle Battye (Manager) (UK) represented eUROGEN at the ERN CG meeting on 25 June 2018 in Brussels.  These meetings are held three times a year, chaired by the European Commission (EC) DG...

We held our 2nd Annual Strategic Board meeting in Noordwijk from 11-12 June 2018, with 43 attendees representing our Coordinating Team, Operational Board, Workstreams, Health Care Providers (HCPs) and European Patient Advocacy Group (ePAG), as well as the European...

The European Reference Network (ERN) eUROGEN is already the most proactive of the 24 ERNs approved and funded by the European Commission (EC), announced Mrs. Michelle Battye (GB) in a specialty session at the 33rd edition of the Annual...

Prof Chris Chapple introduces EU Commissioner Vytenis Andriukaitis at the EAU18 opening ceremony, after a dynamic performance by the Copenhagen Drummers. We also get a behind the scenes look at a conversation between Prof Chapple and the EU Commissioner...

A major international survey has found that around a quarter of patients are not receiving the recommended treatment for cancer of the penis. It also found that these patients had half the survival rate of those who were treated...